NCT04862650 2026-02-10
Cemiplimab, Low-Dose Paclitaxel and Carboplatin for the Treatment of Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck
Ohio State University Comprehensive Cancer Center
Phase 2 Active not recruiting
Ohio State University Comprehensive Cancer Center
Fondazione IRCCS Policlinico San Matteo di Pavia
H. Lee Moffitt Cancer Center and Research Institute
M.D. Anderson Cancer Center